Literature DB >> 19460332

Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort.

Shobha Narahari1, Abida Juwle, Subhankar Basak, Dhananjaya Saranath.   

Abstract

Viral hepatitis represents a major global health problem with 170 million Hepatitis C Virus (HCV) carriers worldwide, and 12-13 million HCV carriers in India. HCV genotypes are of clinical significance in indicating drug responsiveness and prognosis of the patient. The HCV genotypes are of epidemiologic significance as well, as they are indicative of transmission route of infection and have not been extensively studied in the Indian context. In the current study, HCV genotyping was examined in 2118 patients from different geographic regions of India. HCV was detected by PCR amplification of 5' UTR and core-envelope1 regions, followed by genotyping using nucleotide sequencing and analysis with NCBI tool (http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi). HCV genotype distribution in the 2118 Indian patients demonstrated prevalence of HCV3 (3a/3b primarily) in 62% and HCV1 (1a/1b primarily) in 31% patients. The predominance of HCV3 was significant in northern (p=0.01) and eastern (p=0.008) regions of India. HCV types 2, 4, 5, and 6 were detected in 0.05-4.5% of the patient group. Thus, our studies demonstrate HCV genotype prevalence in the cohort group in different regions of India.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460332     DOI: 10.1016/j.meegid.2009.04.001

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  28 in total

Review 1.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C.

Authors:  Pn Rao; Abraham Koshy; Jacob Philip; Narayanan Premaletha; Joy Varghese; Krishnasamy Narayanasamy; Samir Mohindra; Nitin Vikas Pai; Manoj Kumar Agarwal; Ashoknanda Konar; Hasmukh B Vora
Journal:  World J Hepatol       Date:  2014-07-27

3.  Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients.

Authors:  Amit Goel; Dharmendra Singh Bhadauria; Anupma Kaul; Narayan Prasad; Amit Gupta; Raj Kumar Sharma; Praveer Rai; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2017-03-27

Review 4.  Tackling the Hepatitis C Disease Burden in Punjab, India.

Authors:  Radha K Dhiman; Sandeep Satsangi; Gagandeep S Grover; Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2016-09-07

5.  Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern India.

Authors:  Vinod K Dixit; Jayanta K Ghosh; Sangey C Lamtha; Pankaj Kaushik; Sundeep K Goyal; Manas K Behera; Neha Singh; Ashok K Jain
Journal:  J Clin Exp Hepatol       Date:  2014-06-18

Review 6.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

7.  Complete genome sequences of hepatitis C virus subtype 3i and 3a subtype isolates from India.

Authors:  Gouri M Gupte; Ashwini Y Ramdasi; Anupriya S Kulkarni; V A Arankalle
Journal:  Indian J Gastroenterol       Date:  2010-07-25

8.  Treatment of chronic genotype-3 hepatitis C virus infection using direct-acting antiviral agents: An Indian experience.

Authors:  Amit Goel; Rajat Bhargava; Praveer Rai; Rakesh Aggarwal
Journal:  Indian J Gastroenterol       Date:  2017-06-28

9.  Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Authors:  David R Nelson; Yves Benhamou; Wan-Long Chuang; Eric J Lawitz; Maribel Rodriguez-Torres; Robert Flisiak; Jens W F Rasenack; Wiesław Kryczka; Chuan-Mo Lee; Vincent G Bain; Stephen Pianko; Keyur Patel; Patrick W Cronin; Erik Pulkstenis; G Mani Subramanian; John G McHutchison
Journal:  Gastroenterology       Date:  2010-07-01       Impact factor: 22.682

10.  Viral hepatitis: Indian scenario.

Authors:  Sandeep Satsangi; Yogesh K Chawla
Journal:  Med J Armed Forces India       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.